Sulphation and fibronectin-binding properties of heparan sulphate glycosaminoglycans from transformed cultured human keratinocytes. by Brown, K. W.
Br. J. Cancer (1987), 55, 295-297 .j The Macmillan Press Ltd., 1987
SHORT COMMUNICATION
Sulphation and fibronectin-binding properties of heparan sulphate
glycosaminoglycans from transformed cultured human keratinocytes
K.W. Brown*
Department ofCancer Studies, CRC Laboratories, The Medical School, University ofBirmingham, Birmingham, B15 2TJ, UK.
We have recently demonstrated that both SV40-transformed
human keratinocytes and keratinocytes derived from human
squamous cell carcinomas (SCCs) retain the ability to
produce an extracellular matrix (ECM) (Brown & Parkinson,
1984; 1985). However, these cells do show certain novel
quantitative changes in their ECM when compared to
normal keratinocytes, the most consistent of these changes
being (1) a decrease in entactin production and (2) a shift in
glycosaminoglycan (GAG) production from hyaluronic acid
to heparan sulphate (Brown & Parkinson, 1984; 1985).
In contrast, the transformation of fibroblastic cells
normally causes them to lose their ECM and to show a shift
in GAG production from sulphated GAGs to hyaluronic
acid (Alitalo & Vaheri, 1982). One important factor in this
loss of ECM is probably a decrease in the sulphation of
heparan sulphate, which has been reported in several systems
(Underhill & Keller, 1975; Winterbourne & Mora, 1981;
Stamatoglou & Keller, 1983; David & van den Berghe, 1983;
Robinson et al., 1984). This decrease in sulphation reduces
the affinity of heparan sulphate for fibronectin (Stamatoglou
& Keller, 1983; Robinson et al., 1984) and may therefore
interfere with the complex interactions between the various
glycoprotein and proteoglycan components of the ECM, in
which heparan sulphate is thought to play a central role
(Gallagher et al., 1986).
In the light of the latter results and our own studies of the
keratinocyte ECM, we have compared the sulphation and
fibronectin-binding properties of the heparan sulphate GAGs
produced by normal and transformed keratinocytes, in order
to address two questions: (1) Might changes in heparan
sulphate sulphation play a role in some of the ECM
alterations seen in transformed keratinocytes, and (2) Do
transformed keratinocytes show a decrease in heparan
sulphate sulphation similar to that observed in transformed
fibroblasts, or as with many other aspects of their ECM, do
they demonstrate a different pattern ofchanges?
Human epidermal keratinocytes were cultured using the
methods of Rheinwald and Green (Rheinwald, 1980), as
previously described (Brown & Parkinson, 1983). The cells
used in this study were: normal strains Z and R (derived
from newborn foreskin and the foreskin of a 10-year-old
respectively); SV6-1 Bam/HFK, an SV40 transformed
keratinocyte cell line (Brown & Parkinson, 1984; Brown &
Gallimore, manuscript in preparation); and SCC4, SCC9,
SCC12B.2, SCC12F.2, SCC15, SCC25 and SCC27, lines
derived from human SCCs of the tongue or epidermis
(Rheinwald & Beckett, 1981). The properties of all these
keratinocytes have been described in detail elsewhere (Brown
& Parkinson, 1984, 1985 and reference therein).
Seven day-old cultures of keratinocytes were metabolically
labelled with 3H-glucosamine and/or 35SO2- as previously
described (Brown & Parkinson, 1984, 1985). Cell surface
GAGs were then released from the cell surface by trypsin
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and further purified by pronase digestion and ethanol
precipitation in the presence of carriers GAGs, exactly as
described previously (Brown & Parkinson, 1984). Nitrous
acid treatment was by the method of Wusteman (1979), as
described previously (Brown & Parkinson, 1983).
The sulphation of GAG samples was analysed by high
performance liquid chromatography on a DEAE column (as
described in the legend to Figure 1), or by electrophoresis on
cellulose acetate in 0.1 M HCI, as described by Wessler (1971).
The affinity of heparan sulphate GAGs for fibronectin was
investigated by affinity chromatography, using columns of
fibronectin (purified from swine serum (Engvall & Ruoslahti,
1977)) covalently linked to Sepharose 4B-CL (Syska et al.,
1974). Elution conditions for the affinity columns were as
described in the legend to Figure 3.
High performance liquid chromatography using a DEAE
column separated the GAG preparation from normal
keratinocytes into 3 well resolved peaks (Figure IA), one of
which (peak I) was non-sulphated. Electrophoretic
separations have previously shown that identical GAG
preparations from normal keratinocytes are composed of
hyaluronic acid (-.60%), heparan sulphate (-.30%) and
chondroitin sulphates (-10%) (Brown & Parkinson, 1983).
Therefore, by comparison with the electrophoresis results the
peaks from the DEAE column were preliminarily identified
as hyaluronic acid (peak I), heparan sulphate (peak II) and
chondroitin sulphate (peak III).
When 3H-labelled GAGs from transformed keratinocytes
or normal strain Z were co-chromatographed with 35S-
labelled GAGs from normal strain R, it was found that in
all cases except SCC27, peak II eluted at an identical or
slightly higher conductivity than peak II from strain R
(representative profiles are presented in Figures 1D and 1E).
However, in the case of the SCC line SCC27, peak II
consistently eluted at a lower conductivity than peak II from
strain R (Figure IB, representative of 4 experiments). Peak
II was definitively identified as heparan sulphate by
demonstrating that it could be degraded by nitrous acid
(Figure IC).
These DEAE chromatography results demonstrated an
alteration in the polyanionic properties of SCC27 heparan
sulphate as compared to normal keratinocytes. GAG
sulphation was therefore specifically investigated, using an
electrophoretic method in which GAG migration is directly
proportional to the degree of sulphation (Wessler, 1971).
Electrophoresis of GAGs from normal keratinocytes
separated 2 major species; an unsulphated GAG comigrating
with hyaluronic acid and a sulphated GAG which migrated
slightly behind a chondroitin sulphate standard; and a minor
GAG which comigrated with chondroitin sulphate (Figure 2,
lanes 1 and 2). The major sulphated GAG was shown to be
heparan sulphate by nitrous acid degradation (Figure 2,
lanes 12 and 13). Comparison of GAGs from normal and
transformed keratinocytes (Figure 2, lanes 2 to I 1)
demonstrated that their heparan sulphates all had almost
identical mobilities, with the exception of SCC27, whose
heparan sulphate migrated more slowly (Figure 2, lane 9).
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Figure 1 High performance liquid chromatography of GAGS.
Samples of radiolabelled GAGs (2 to 10iil) were applied to a
7.5 x 150mm TSK545 DEAE column (LKB instruments,
Croydon, Surrey, UK) in 200ul of 50mM tris-HCI pH7.2,
containing 0.15M NaCI, and the column was then washed with
15ml of the same buffer. GAGs were eluted with a 60ml linear
gradient of 0.15M to 0.8M NaCl in 50mM tris-HCI pH7.2. Flow
rate was I mlmin-I and 1 ml fractions were assayed for
conductivity and radioactivity.
a: normal strain R keratinocyte GAGs, double labelled with 3H-
glucosamine and 3-SO4; b: comparison of SCC27 (3H-labelled)
and strain R (35S-labelled); c: comparison of untreated SCC27
GAGs (3H-labelled) with nitrous acid-treated strain R GAGs
(35S-labelled). Note that, as expected, peak II (heparan sulphate)
is only removed in the 35S-labelled sample (strain R); d:
comparison of SCC15 (3H-labelled) and strain R (35S-labelled)
and e: SCC4 (3H-labelled) and strain R (35S-labelled).
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Figure 3 Fibronectin affinity chromatography of heparan
sulphates. Fractions from the DEAE column which contained
heparan sulphate GAGs were pooled, dialysed in 10mm tris-HCI
pH7.2 and applied to 2ml columns of fibronectin-sepharose
equilibrated in 10mm~tris-HCI pH7.2. After washing with 10 ml
of this buffer, GAGs were eluted with a 20ml linear gradient of
0 to 0O5m NaCI in 10mm tris-HCI pH7.2 (no further GAGs were
eluted by washing with 1 m NaCI). 1 ml fractions were assayed
for conductivity and radioactivity.
A; comparison of SCC27 (3H) and strain R (31S), B; SCC15(3H)
and R(31S) and C; SCC4(3H) and R(35S).
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Figure 2 Cellulose acetate electrophoresis ofGAGS. Radiolabelled GAG samples (10pl) containing approximately 20,000dpm and
equal amounts of carrier GAGs (hyaluronic acid (HA), chondroitin sulphate (CS), and heparin (HP)) were applied to cellulose
acetate strips (Celagram II, Shandon Southern) and electrophoresed for 3 h at 25 V in 0.1 M HCI. Carrier GAGs were stained in
alcian blue, then the sheets were dried and soaked in 30% (w/v) diphenyloxazole in ether (Bonner & Stedman, 1978) and exposed
to preflashed Kodak X-Omat RP film at -30°C.
Lane l; strain R, 35S labelled, 2; strain R, 3H labelled, 3; SCC4 (3H), 4; SCC9 (3H), 5; SCC 12B.2 (3H), 6; SCC 12F.2 (3H), 7;
SCC15 (3H), 8; SCC25 (3H), 9; SCC27 (3H), 10; SV6-I Bam/HFK low passage (3H), 11; SV6-I Bam/HFK high passage (3H).
Lanes 12 and 13 come from a different experiment and show SCC12B.2 (3H-labelled) before (lane 12) and after (lane 13) digestion
with nitrous acid. Bars denote the position of unlabelled carrier GAGs. 0 indicates the origin and + the anode.
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The heparan sulphate from SCC27 was therefore
undersulphated in comparison to all other cell strains
examined.
The binding of the heparan sulphate GAGs to fibronectin
was examined by affinity chromatography (Figure 3). The
heparan sulphate obtained from SCC27 showed a reduced
affinity for fibronectin, as demonstrated by its elution at a
lower salt concentration than the heparan sulphate GAG
from normal keratinocytes (Figure 3A). In contrast, the
heparan sulphates from two other representative transformed
cell lines, SCC15 (Figure 3B) and SCC4 (Figure 3C) co-
eluted with the heparan sulphate from normal keratinocytes.
This study has clearly demonstrated that in the majority of
transformed keratinocytes, heparan sulphate GAGs show a
similar degree of sulphation and affinity for fibronectin as
those derived from normal keratinocytes. Thus an alteration
in the overall level of heparan sulphate sulphation is almost
certainly not a factor in the ECM alterations which are
observed in transformed keratinocytes (Brown & Parkinson,
1984; 1985); although we cannot rule out the possibility that
changes in the distribution of ester (o) sulphate groups may
have occurred, since this would not have been detected by
the methods employed here. Furthermore, these results
contrast the many other reports of undersulphated heparan
sulphates being produced by other types of transformed cells
(Underhill & Keller, 1975; Winterbourne & Mora, 1981;
Stamatoglou & Keller, 1983; David & van den Berghe, 1983;
Robinson et al., 1984).
The single SCC line which produced an undersulphated
heparan sulphate (SCC27) clearly showed reduced heparan
sulphate affinity for fibronectin, as has been reported in
other systems (Stamatoglou & Keller, 1983; Robinson et al.,
1984). Although SCC27 has only small amounts of
fibronectin in its ECM, it also only secretes small amounts
of fibronectin into the culture medium (Brown & Parkinson,
1985); and so the low amounts of fibronectin in its ECM
could be due to low levels of synthesis, rather than a failure
in ECM assembly due to the production of an
undersulphated heparan sulphate. SCC27 shows no other
obvious distinguishing features from the other SCC lines
(Brown & Parkinson, 1985), which strongly suggests the
production of an undersulphated heparan sulphate is not
essential for either the expression of a transformed
phenotype or for tumorigenicity in the keratinocyte.
Furthermore, since our SV40 transformed line SV6-1
Bam/HFK produces invasive SCCs in nude mice (at high
passage levels, Brown & Gallimore, manuscript in
preparation), these results imply that even malignant
transformation in the keratinocyte does not require a
decrease in heparan sulphate sulphation.
However, these findings are consistent with the idea that
heparan sulphate, by virtue of its ability to interact with
other ECM components, plays an important role in
promoting overall matrix stability; since the transformed
keratinocytes retain an ECM (Brown & Parkinson, 1984,
1985; Bernard et al., 1985; Edelman et al., 1985), whereas
most other transformed cells do not (Alitalo & Vaheri,
1982).
These results indicate that at least as far as overall
sulphation and fibronectin binding are concerned, the
heparan sulphate GAGs from the majority of transformed
keratinocytes are structurally normal. It is therefore probable
that interactions between heparan sulphate and other ECM
components are relatively undisrupted in transformed
keratinocytes. This, and previous reports on the ECM of
transformed keratinocytes in vitro (Brown & Parkinson,
1984, 1985; Bernard et al., 1985; Edelman et al., 1985) imply
that malignant transformation of the keratinocyte requires
the continued (or even increased) production of an intact
and functional ECM. This proposal is in agreement with a
recent report which showed that even invading SCCs retain
basement membrane production, as demonstrated by
immunohistochemical staining for type IV collagen
(Gusterson et al., 1984), and with other reports of an
apparent increase in fibronectin (Nelson et al., 1983;
Grimwood et al., 1984) and laminin (Nelson et al., 1983)
production in basal cell carcinomas.
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